• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • INTERACTIVE MAP
  • Location Profiles
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home News & Updates Page 12

News & Updates

Stay up to date with new data, maps, infographics, blog posts, and other educational resources to help you better understand the viral hepatitis epidemic in the U.S. and its intersection with the opioid epidemic.

Categories:

Toolkits Awareness Days What's New in Viral Hepatitis Hep A Hep B Hep C Opioids COVID-19

January 19, 2022

Welcoming the 2021-2022 Vu Fellows

December 21, 2021

2021: A Year in Review

Read More

December 9, 2021

What's New in Viral Hepatitis - December

Read More

November 18, 2021

Dr. Philip Spradling on the Hepatitis B Care Cascade

Read More

November 3, 2021

Liver Cancer and Viral Hepatitis

Read More

November 3, 2021

Dr. Samuel So on Liver Cancer & Hepatitis B and C

Read More

October 26, 2021

Reopening the 2021-2022 Vu Fellowship

Read More

October 11, 2021

What’s New in Viral Hepatitis October 2021

Read More

August 23, 2021

Dr. Eric Hall on County-Level Opioid Prescribing and Overdose Mortality Rates

Read More

August 23, 2021

Opioid Prescription and Overdose Mortality Rates in the U.S. at the County-Level

  • Page 1
  • Interim pages omitted …
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Interim pages omitted …
  • Page 20

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2026 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.